- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 211/46 - Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
Patent holdings for IPC class C07D 211/46
Total number of patents in this class: 567
10-year publication summary
|
51
|
48
|
42
|
34
|
30
|
38
|
36
|
29
|
22
|
8
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Amicus Therapeutics, Inc. | 346 |
19 |
| Taisho Pharmaceutical Co., Ltd. | 868 |
12 |
| Theravance Biopharma R&D IP, LLC | 460 |
11 |
| Alectos Therapeutics Inc. | 49 |
9 |
| Novartis AG | 10886 |
8 |
| AstraZeneca AB | 2928 |
8 |
| Takeda Pharmaceutical Company Limited | 2712 |
8 |
| Recurium IP Holdings, LLC | 134 |
8 |
| Centre National de La Recherche Scientifique | 10408 |
7 |
| Pfizer Limited | 189 |
7 |
| Bristol-myers Squibb Company | 4879 |
6 |
| Otsuka Pharmaceutical Co., Ltd. | 1499 |
6 |
| Gen1e Lifesciences Inc. | 25 |
6 |
| F. Hoffmann-La Roche AG | 7934 |
5 |
| AstraZeneca UK Limited | 655 |
5 |
| FUJIFILM Corporation | 29295 |
5 |
| JSR Corporation | 2514 |
5 |
| BioMarin Pharmaceutical Inc. | 377 |
5 |
| Daiichi Sankyo Company, Limited | 1854 |
5 |
| Eastman Chemical Company | 2215 |
5 |
| Other owners | 417 |